Developer docs
API playgroundTry for free, no card

Search company profiles

Centre for Cellular and Molecular Platforms

Full company profile

uuid0002z46

Namestring
Centre for Cellular and Molecular Platforms
Legal namestring
Centre for Cellular and Molecular platforms
Websiteurl
ccamp.res.in
Company typeenum
Private
Founded yearint
2009
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersBangalore, India
HQ citystring
Bangalore
HQ countrystring
India
HQ regionstring
Asia
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
biotechnology research services, bio-incubation services, life sciences technology platforms, biotech startup acceleration, entrepreneurship development programs
NAICS code3 codes
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
  • Research and Development in the Physical, Engineering, and Life Sciences54171
  • Scientific Research and Development Services5417
SIC code2 codes
  • Services-Commercial Physical & Biological Research8731
  • Services-Testing Laboratories8734
Product category
Biotechnology Research and Innovation Services
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model2 records
1Government Funding
TypeLicensing Royalties
Description

C-CAMP is an initiative supported by Department of Biotechnology, Govt of India, functioning as a government-funded research and innovation catalyst since 2009

ccamp.res.in
2Technology Services
TypeProfessional Services
Description

Provides research, development, training and services through state-of-the-art technology platforms to investigators and researchers

ccamp.res.in
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Infrastructure, Operations, Marketing or Sales
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 of 5 records shown
1National Bio Entrepreneurship Competition (NBEC)
Description

India's largest bio entrepreneurship competition offering up to Rs 20 crore in cash prizes and investment opportunities, with over 21,000 applications received since 2017.

yourstory.com
+4 more records
Core offering1 text field

C-CAMP operates as a government-supported catalyst for cutting-edge research and innovation in life sciences, providing state-of-the-art technology platforms, bio-incubation facilities, seed funding, mentorship programs, and entrepreneurship competitions. It enables biotech researchers, startups, and entrepreneurs through research, development, training, and service support across multiple verticals including diagnostics, medtech, agri-innovation, antimicrobial resistance, and bioenergy.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • 21,000+ applications received and 130+ winning ideas backed since 2017
+2 more records
Product overview1 text field

C-CAMP (Centre for Cellular and Molecular Platforms) is a Department of Biotechnology initiative established in 2009 as part of the Bangalore Life Science Cluster (BLiSC). It operates as a catalyst for cutting-edge research and innovation in life sciences through a multi-faceted portfolio of programs and services. The core offering includes state-of-the-art Technology Platforms providing research, development, training, and services in life sciences. Supporting this are diverse incubation and acceleration programs including Incubation Services, Seed Funding Programs, Discovery to Innovation Accelerator (DIA), DST NIDHI C-CAMP Accelerator, and the National Bio Entrepreneurship Competition (NBEC) as flagship initiative. C-CAMP also runs specialized vertical programs covering AMR, MedTech Rapid Prototyping, Indigenous Diagnostics (InDx), Bio for Climate & Sustainability, Agri Innovation, and WE-Bio for women entrepreneurs. The organization facilitates bioscience research and entrepreneurship through technology platforms, mentorship, and funding support, serving as an ecosystem enabler for over 4,000 biotech startups.

Product and service13 records
1Bio-Incubation Services
CategoryIncubation Service
2Seed Funding Programs
CategoryFunding Program
3Technology Platforms / Technology Services
CategoryTechnology Service
4Discovery to Innovation Accelerator (DIA)
CategoryAcceleration Program
5DST NIDHI C-CAMP Accelerator
CategoryAcceleration Program
6Bioethanol Refinery and Energy Centre (BREC)
CategoryBioenergy Service
7MedTech Rapid Prototyping
CategoryPrototyping Service
8National Bio Entrepreneurship Competition (NBEC)
CategoryCompetition Program
9Indigenous Diagnostics (InDx) / National Diagnostics Catapult (NDxC)
CategoryDiagnostics Program
10AMR (Antimicrobial Resistance) Initiative
CategoryResearch Program
11Centre of Excellence for Agri Innovation
CategoryAgri Innovation Program
12WE-Bio (Women Entrepreneurs in Biotechnology)
CategoryEntrepreneurship Program
13Centre of Excellence for AI in Biotechnology (AI-CoE)
CategoryAI Research Centre
Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership7 partners
1Energy PSUs (HPCL, ONGC, IOCL, BPCL, GAIL, Oil India Limited, Petronet LNG)
Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2026-07-22
Description

Seven major public sector energy companies backing the Grand Butanol Challenge (₹12.5 crore initiative) to accelerate indigenous bio-butanol production supporting startups at Technology Readiness Levels 4 to 7.

chemindigest.com
Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2026-07-17
Description

Joint launch of the MC²+ Grand Butanol Challenge on July 17, 2026 - a national innovation programme sourcing indigenous solutions for bio-Iso-Butanol and N-Butanol production. Prize pool up to ₹5 crores and grant pool up to ₹7.5 crores.

Strategic tierMajorTypeGTM or Marketing PartnerAnnounced on2026-07-09
Description

C-CAMP co-hosts BioWave Annual Conference #2 with Wadhwani Innovation Network, along with Omnivore, Nucleate, and SOS Ventures, to spotlight India's growing bioeconomy and accelerate venture capital investment.

Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2026-04-23
Description

Five-year strategic partnership establishing Indo-UK Life Sciences Innovation Corridor for bilateral research, innovation, and entrepreneurial collaboration between Bengaluru and London. Corridors create bi-directional exchange platform for researchers, innovators, and startups.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-04-17
Description

Partnership for Centre of Excellence for AI in Biotechnology (AI-CoE) at IBAB in Electronics City, Bengaluru with ₹20 crore budget over four years, strengthening Karnataka's research ecosystem in deep tech and biotechnology.

Strategic tierCoreTypeTechnology or Integration
Description

Strategic tie-up with Agilent to boost access to advanced life sciences innovation in biopharma, biologics, and vaccines sectors.

Strategic tierMajorTypeStrategic or Co-development Partner
Description

C-CAMP partnered with IIT Madras, IIM Ahmedabad, NCL, and BITS to establish studio structures for incubating deep tech startups with target of supporting 100 startups annually.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

BIRAC is a Government of India enterprise under the Department of Biotechnology that funds and incubates biotech startups through the BioNEST network and various funding schemes. It is the most direct peer to C-CAMP as both operate as national-level bio-innovation catalysts with overlapping startup funnels (NBEC vs. BIG, BioNEST incubators) and overlapping funding sources.

TypeDirect peer
Description

IKP Knowledge Park is one of India's earliest life sciences incubators based in Hyderabad with laboratory infrastructure and startup acceleration services. It is directly comparable to C-CAMP in providing bio-incubation facilities, mentor networks, and seed funding, serving an overlapping biotech startup pool in South India.

3Bangalore Bioinnovation Centre (BBC)
TypeDirect peer
Description

Bangalore Bioinnovation Centre is a Karnataka government-supported bio-incubator located in the same city as C-CAMP and offering bio-incubation, lab space, and mentorship. It is a direct local peer competing for the same Bengaluru biotech startup pool, often with overlapping state-level funding sources and government stakeholders.

TypeDirect peer
Description

IBAB is a Bengaluru-based bioinformatics research and training institution that is already a strategic partner of C-CAMP via the Centre of Excellence for AI in Biotechnology (AI-CoE). It is comparable in operating model (government-supported biotech research/training hub) and directly relevant given the co-development partnership.

TypeDirect peer
Description

BioGenerator is a St. Louis-based nonprofit biotech startup generator that provides lab space, seed funding, and founder support for life sciences ventures. It is a directly comparable mission-aligned peer to C-CAMP as both operate as bio-incubation/entrepreneurship hubs supporting translational biotech startups.

TypeDirect peer
Description

IndieBio is the world's largest synthetic biology and biotech accelerator program. It is a direct functional peer to C-CAMP's accelerator/DIA programs, providing seed funding, mentorship, and lab infrastructure to biotech founders, with similar program structure (cohort-based acceleration and equity participation).

TypeDirect peer
Description

MBC BioLabs is a San Francisco-based biotech incubator offering fully equipped lab space and mentorship to early-stage life sciences startups. It is comparable to C-CAMP in providing turnkey bio-lab infrastructure and startup support services, and serves a similar translational research-to-startup pipeline.

TypeRegional player
Description

BioM is a Munich-based biotech cluster management organization supporting biotech startups and SMEs in the Bavarian/greater Munich region. It is comparable to C-CAMP as an ecosystem orchestrator but operates primarily in Germany rather than India, making it a regional peer rather than direct competitor.

TypeBroad incumbent
Description

JLABS is the no-strings-attached biotech incubator network of Johnson & Johnson Innovation operating across multiple geographies. It is comparable in offering lab infrastructure and startup support for healthcare/biotech founders, but as part of a much larger pharmaceutical conglomerate's broader innovation portfolio.

TypeBroad incumbent
Description

Agilent is a global life sciences instrumentation company that already has an active strategic tie-up with C-CAMP. As a broad incumbent, it supplies the analytical instruments and platforms that C-CAMP's researchers use, and overlaps in the biopharma, biologics, and vaccines research infrastructure segment.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors2 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment7 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Centre for Cellular and Molecular Platforms

Biotechnology Research and Innovation Servicesccamp.res.in

Centre for Cellular and Molecular Platforms firmographics

Firmographics
Name
Centre for Cellular and Molecular Platforms
Legal name
Centre for Cellular and Molecular platforms
Website
https://ccamp.res.in
Company type
Private
Founded year
2009
Operating status
Operating
Headcount range
101–250 employees
Ownership category
akta.pro rank

Where Centre for Cellular and Molecular Platforms is headquartered

Location

Headquarters

HQ city
Bangalore
HQ country
India
HQ region
Asia

Offices1 record

Markets served

Centre for Cellular and Molecular Platforms business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Technology or R&D, Infrastructure, Operations, Marketing or Sales

Revenue model

  1. Government Funding: C-CAMP is an initiative supported by Department of Biotechnology, Govt of India, functioning as a government-funded research and innovation catalyst since 2009
  2. Technology Services: Provides research, development, training and services through state-of-the-art technology platforms to investigators and researchers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels4 records

Centre for Cellular and Molecular Platforms product offering

Product offering

Core offering

C-CAMP operates as a government-supported catalyst for cutting-edge research and innovation in life sciences, providing state-of-the-art technology platforms, bio-incubation facilities, seed funding, mentorship programs, and entrepreneurship competitions. It enables biotech researchers, startups, and entrepreneurs through research, development, training, and service support across multiple verticals including diagnostics, medtech, agri-innovation, antimicrobial resistance, and bioenergy.

Product overview

C-CAMP (Centre for Cellular and Molecular Platforms) is a Department of Biotechnology initiative established in 2009 as part of the Bangalore Life Science Cluster (BLiSC). It operates as a catalyst for cutting-edge research and innovation in life sciences through a multi-faceted portfolio of programs and services. The core offering includes state-of-the-art Technology Platforms providing research, development, training, and services in life sciences. Supporting this are diverse incubation and acceleration programs including Incubation Services, Seed Funding Programs, Discovery to Innovation Accelerator (DIA), DST NIDHI C-CAMP Accelerator, and the National Bio Entrepreneurship Competition (NBEC) as flagship initiative. C-CAMP also runs specialized vertical programs covering AMR, MedTech Rapid Prototyping, Indigenous Diagnostics (InDx), Bio for Climate & Sustainability, Agri Innovation, and WE-Bio for women entrepreneurs. The organization facilitates bioscience research and entrepreneurship through technology platforms, mentorship, and funding support, serving as an ecosystem enabler for over 4,000 biotech startups.

Differentiator

Problem solved

Functional benefit

Brands

  • National Bio Entrepreneurship Competition (NBEC): India's largest bio entrepreneurship competition offering up to Rs 20 crore in cash prizes and investment opportunities, with over 21,000 applications received since 2017.
  • National Diagnostics Catapult (NDxC)
  • MC² Grand Butanol Challenge
  • Indo-UK Life Sciences Innovation Corridor
  • Grand Butanol Challenge

Products and services

  • Bio-Incubation Services
  • Seed Funding Programs
  • Technology Platforms / Technology Services
  • Discovery to Innovation Accelerator (DIA)
  • DST NIDHI C-CAMP Accelerator
  • Bioethanol Refinery and Energy Centre (BREC)
  • MedTech Rapid Prototyping
  • National Bio Entrepreneurship Competition (NBEC)
  • Indigenous Diagnostics (InDx) / National Diagnostics Catapult (NDxC)
  • AMR (Antimicrobial Resistance) Initiative
  • Centre of Excellence for Agri Innovation
  • WE-Bio (Women Entrepreneurs in Biotechnology)
  • Centre of Excellence for AI in Biotechnology (AI-CoE)

Quantifiable outcome

  • 21,000+ applications received and 130+ winning ideas backed since 2017
  • +2 more outcomes

Companies that use Centre for Cellular and Molecular Platforms

Customer profile

Named customers3 records

Segments4 records

Ideal customer profiles3 records

Centre for Cellular and Molecular Platforms technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

Centre for Cellular and Molecular Platforms partnerships and signals

Strategic signal

Partnerships

Seven partnerships are on record, tiered flagship, major and core.

  • Energy PSUs (HPCL, ONGC, IOCL, BPCL, GAIL, Oil India Limited, Petronet LNG)flagshipStrategic or Co-development Partner · 22 July 2026Seven major public sector energy companies backing the Grand Butanol Challenge (₹12.5 crore initiative) to accelerate indigenous bio-butanol production supporting startups at Technology Readiness Levels 4 to 7.
  • MC² FoundationflagshipStrategic or Co-development Partner · 17 July 2026Joint launch of the MC²+ Grand Butanol Challenge on July 17, 2026 - a national innovation programme sourcing indigenous solutions for bio-Iso-Butanol and N-Butanol production. Prize pool up to ₹5 crores and grant pool up to ₹7.5 crores.
  • Wadhwani Innovation NetworkmajorGTM or Marketing Partner · 9 July 2026C-CAMP co-hosts BioWave Annual Conference #2 with Wadhwani Innovation Network, along with Omnivore, Nucleate, and SOS Ventures, to spotlight India's growing bioeconomy and accelerate venture capital investment.
  • Imperial College LondonflagshipStrategic or Co-development Partner · 23 April 2026Five-year strategic partnership establishing Indo-UK Life Sciences Innovation Corridor for bilateral research, innovation, and entrepreneurial collaboration between Bengaluru and London. Corridors create bi-directional exchange platform for researchers, innovators, and startups.
  • Institute of Bioinformatics and Applied Biotechnology (IBAB)coreStrategic or Co-development Partner · 17 April 2026Partnership for Centre of Excellence for AI in Biotechnology (AI-CoE) at IBAB in Electronics City, Bengaluru with ₹20 crore budget over four years, strengthening Karnataka's research ecosystem in deep tech and biotechnology.
  • AgilentcoreTechnology or IntegrationStrategic tie-up with Agilent to boost access to advanced life sciences innovation in biopharma, biologics, and vaccines sectors.
  • IIT MadrasmajorStrategic or Co-development PartnerC-CAMP partnered with IIT Madras, IIM Ahmedabad, NCL, and BITS to establish studio structures for incubating deep tech startups with target of supporting 100 startups annually.

Scale indicators5 records

Recent moves6 records

Expansion highlights6 records

Centre for Cellular and Molecular Platforms competitors and assessment

Company assessment

Direct peers

  • Biotechnology Industry Research Assistance Council (BIRAC): BIRAC is a Government of India enterprise under the Department of Biotechnology that funds and incubates biotech startups through the BioNEST network and various funding schemes. It is the most direct peer to C-CAMP as both operate as national-level bio-innovation catalysts with overlapping startup funnels (NBEC vs. BIG, BioNEST incubators) and overlapping funding sources.
  • IKP Knowledge Park: IKP Knowledge Park is one of India's earliest life sciences incubators based in Hyderabad with laboratory infrastructure and startup acceleration services. It is directly comparable to C-CAMP in providing bio-incubation facilities, mentor networks, and seed funding, serving an overlapping biotech startup pool in South India.
  • Bangalore Bioinnovation Centre (BBC): Bangalore Bioinnovation Centre is a Karnataka government-supported bio-incubator located in the same city as C-CAMP and offering bio-incubation, lab space, and mentorship. It is a direct local peer competing for the same Bengaluru biotech startup pool, often with overlapping state-level funding sources and government stakeholders.
  • Institute of Bioinformatics and Applied Biotechnology (IBAB): IBAB is a Bengaluru-based bioinformatics research and training institution that is already a strategic partner of C-CAMP via the Centre of Excellence for AI in Biotechnology (AI-CoE). It is comparable in operating model (government-supported biotech research/training hub) and directly relevant given the co-development partnership.
  • BioGenerator: BioGenerator is a St. Louis-based nonprofit biotech startup generator that provides lab space, seed funding, and founder support for life sciences ventures. It is a directly comparable mission-aligned peer to C-CAMP as both operate as bio-incubation/entrepreneurship hubs supporting translational biotech startups.
  • IndieBio: IndieBio is the world's largest synthetic biology and biotech accelerator program. It is a direct functional peer to C-CAMP's accelerator/DIA programs, providing seed funding, mentorship, and lab infrastructure to biotech founders, with similar program structure (cohort-based acceleration and equity participation).
  • MBC BioLabs: MBC BioLabs is a San Francisco-based biotech incubator offering fully equipped lab space and mentorship to early-stage life sciences startups. It is comparable to C-CAMP in providing turnkey bio-lab infrastructure and startup support services, and serves a similar translational research-to-startup pipeline.

Regional players

  • BioM GmbH: BioM is a Munich-based biotech cluster management organization supporting biotech startups and SMEs in the Bavarian/greater Munich region. It is comparable to C-CAMP as an ecosystem orchestrator but operates primarily in Germany rather than India, making it a regional peer rather than direct competitor.

Broad incumbents

  • JLABS (Johnson & Johnson Innovation): JLABS is the no-strings-attached biotech incubator network of Johnson & Johnson Innovation operating across multiple geographies. It is comparable in offering lab infrastructure and startup support for healthcare/biotech founders, but as part of a much larger pharmaceutical conglomerate's broader innovation portfolio.
  • Agilent Technologies: Agilent is a global life sciences instrumentation company that already has an active strategic tie-up with C-CAMP. As a broad incumbent, it supplies the analytical instruments and platforms that C-CAMP's researchers use, and overlaps in the biopharma, biologics, and vaccines research infrastructure segment.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

Centre for Cellular and Molecular Platforms social profiles

Digital presence

Centre for Cellular and Molecular Platforms compliance and trust

Trust signal

Compliance1 record

Centre for Cellular and Molecular Platforms financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Centre for Cellular and Molecular Platforms leadership team

Management profile

Number of profiles

Profiles2 records

Centre for Cellular and Molecular Platforms funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Centre for Cellular and Molecular Platforms M&A and investment

M&A and investment

M&A

Investments7 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Centre for Cellular and Molecular Platforms

What does Centre for Cellular and Molecular Platforms do?

C-CAMP operates as a government-supported catalyst for cutting-edge research and innovation in life sciences, providing state-of-the-art technology platforms, bio-incubation facilities, seed funding, mentorship programs, and entrepreneurship competitions. It enables biotech researchers, startups, and entrepreneurs through research, development, training, and service support across multiple verticals including diagnostics, medtech, agri-innovation, antimicrobial resistance, and bioenergy.

Is Centre for Cellular and Molecular Platforms a public or private company?

Centre for Cellular and Molecular Platforms is a private company. It is classified as state government owned and is currently operating.

When was Centre for Cellular and Molecular Platforms founded?

Centre for Cellular and Molecular Platforms was founded in 2009. It employs 101 to 250 people.

Where is Centre for Cellular and Molecular Platforms based?

Centre for Cellular and Molecular Platforms is headquartered in Bangalore, India, in the Asia region.

How does Centre for Cellular and Molecular Platforms make money?

Two revenue lines are on record. Government Funding is the primary driver. The others are technology Services.

Who are Centre for Cellular and Molecular Platforms's main competitors?

Direct peers on record are Biotechnology Industry Research Assistance Council (BIRAC), IKP Knowledge Park, Bangalore Bioinnovation Centre (BBC), Institute of Bioinformatics and Applied Biotechnology (IBAB), BioGenerator, IndieBio and MBC BioLabs. BioM GmbH is listed as a regional player. Broad incumbents are JLABS (Johnson & Johnson Innovation) and Agilent Technologies.

Does Centre for Cellular and Molecular Platforms have an API?

No public API is recorded for Centre for Cellular and Molecular Platforms.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
YourStoryMC² Foundation launches accelerator for energy deeptech startupsMC² Foundation launched the MC²+ Ignite accelerator program at IIT Madras to support deeptech startups in India's energy sector. The initiative will select approximately 30 startups for up to Rs 2 crore in funding and provide access to pilot sites through partnerships with institutions like IIT Madras, IIT Kanpur, and C-CAMP. This effort aims to bridge gaps in operating assets and growth capital by consolidating technology problem statements from major oil and gas companies.BusinessLineMC² Grand Butanol Challenge launched to identify energy innovations in biotech domainIndia's Centre for Cellular and Molecular Platforms (C-CAMP) has signed a MoU with MC2 Foundation to jointly launch the first edition of the MC²+ Grand Butanol Challenge on 17 July, a national innovation programme aimed at sourcing indigenous solutions for bio-Iso-Butanol and N-Butanol production. The challenge offers a prize pool of up to ₹5 crores and a grant pool of up to ₹7.5 crores, with C-CAMP serving as the exclusive implementation and mentorship partner leveraging its network of over 4,000 biotech startups. India currently consumes around 5.6 million barrels of oil per day and relies on imports for about 90% of this need, making domestic biofuel alternatives a strategic priority for reducing carbon footprint and import dependence.The TribuneCulture meets science to raise awareness on antimicrobial resistanceThe British High Commission hosted the India premiere of Lifeline, a Scottish musical by West End and Broadway artists, in New Delhi to raise public awareness about antimicrobial resistance (AMR). The event brought together senior officials from India's government, healthcare sector, academia, and philanthropy as part of UK-India collaboration on drug-resistant infections. This partnership includes over £10 million invested by UK Research and Innovation through multiple programmes, the Fleming Fund's £600,000 contribution to laboratory strengthening in India, and a £4.8 million partnership between the UK's Global Innovation Fund and Bengaluru's Centre for Cellular and Molecular Platforms focused on environmental threats from antibiotic resistance.Ani NewsCulture meets science to raise awareness on antimicrobial resistanceThe British High Commission hosted the India premiere of "Lifeline," a Scottish musical about antimicrobial resistance (AMR), at the British Council in New Delhi on June 29, 2026. The 60-minute performance by West End and Broadway artists brought together senior figures from the Indian government, philanthropy, industry, academia, and healthcare sectors. The UK has invested over £10 million through UK Research and Innovation programmes, approximately £600,000 through the Fleming Fund for laboratory strengthening and surveillance in India, and a further £4.8 million through the Global Innovation Fund's partnership with Bengaluru's Centre for Cellular and Molecular Platforms to address environmental threats from AMR.IndiaWeb2Agilent and C‑CAMP Expand Collaboration to Boost India’s Biopharma Research InfrastructureAgilent Technologies expanded its collaboration with C-CAMP to provide shared access to advanced analytical and mass spectrometry platforms in India. The initiative aims to reduce entry barriers for startups, academia, and industry, supporting biotherapeutic characterization and next-generation biotherapeutics.Deccan HeraldDiagnostics conclave: National diagnostics conclave in Bengaluru charts India health planThe Centre for Cellular and Molecular Platforms (C-CAMP) hosted the first National Diagnostics Conclave in Bengaluru on Monday to chart a collective vision for diagnostic innovation and health equity in India and other lower and middle-income countries. Experts highlighted gaps in India's diagnostics market, particularly around scalability, regulatory pathway navigation, and international market penetration channels, and suggested creating indigenous regulatory frameworks to explore Global South markets as a unique opportunity for Indian diagnostics developers. The discussions focused on strategic pillars of the National Diagnostics Catapult (NDxC), including strengthening national validation, innovation logistics, and pandemic preparedness.New Indian ExpressE-city set to host Rs 20-cr AI Centre of ExcellenceThe Karnataka cabinet has approved the establishment of a Centre of Excellence for Artificial Intelligence in Biotechnology (AI-CoE) at the Institute of Bioinformatics and Applied Biotechnology (IBAB) in Bengaluru's Electronics City, with a total outlay of Rs 20 crore over four years. The centre will be set up in partnership with IBAB and the Centre for Cellular and Molecular Platforms (C-CAMP), aimed at strengthening Karnataka's research ecosystem in deep tech and biotechnology. The cabinet also approved the transfer of a 51% stake in the Karnataka Technology & Innovation Museum Foundation to Unboxing BLR Foundation for developing a Technology & Innovation Museum at the NGEF campus under a PPP model, with a project cost of Rs 100 crore.BusinessLineKarnataka Cabinet approves Centre of excellence for AI in BengaluruThe Karnataka Cabinet has approved the establishment of a Center of Excellence for Artificial Intelligence in Biotechnology at the Institute of Bioinformatics and Applied Biotechnology in Bengaluru, to be set up over four years with a total outlay of ₹20 crore in partnership with IBAB and the Centre for Cellular and Molecular Platforms. The cabinet also approved construction of a new administrative building for the Kalyana Karnataka Road Transport Corporation in Kalaburagi at an estimated cost of ₹20 crore, and repair works for the Hattikuni canal cluster project in Yadgir district with an outlay of ₹72 crore. These approvals represent a combined investment of ₹112 crore across biotechnology infrastructure, transport, and irrigation projects in the state.MintKarnataka approves AI Centre of Excellence in Bengalurus Electronics City | MintThe Karnataka Cabinet has approved the establishment of a Centre of Excellence for AI in Biotechnology at the Institute of Bioinformatics and Applied Biotechnology (IBAB) in Electronics City, Bengaluru, with a total outlay of ₹20 crore over four years. The CoE is being set up in partnership with IBAB and the Centre for Cellular and Molecular Platforms (C-CAMP), aiming to strengthen Karnataka's leadership in emerging technologies, AI, and deep-tech. Additionally, the Cabinet approved transferring a 51% stake in the Karnataka Technology & Innovation Museum Foundation (KTIMF) to the Unboxing BLR Foundation, with a new Technology & Innovation Museum to be developed under a PPP model at ₹100 crore.The HinduKarnataka approves AI Centre of Excellence at Electronics City in BengaluruThe State Cabinet of Karnataka has approved the establishment of a Centre of Excellence for Artificial Intelligence in Biotechnology (AI-CoE) at the Institute of Bioinformatics and Applied Biotechnology in Electronics City, Bengaluru. The center will be developed over four years with a total outlay of ₹20 crore, in partnership with IBAB and the Centre for Cellular and Molecular Platforms (C-CAMP).